ternatin heptapeptide has been researched along with guanosine triphosphate in 1 studies
| Studies (ternatin heptapeptide) | Trials (ternatin heptapeptide) | Recent Studies (post-2010) (ternatin heptapeptide) | Studies (guanosine triphosphate) | Trials (guanosine triphosphate) | Recent Studies (post-2010) (guanosine triphosphate) |
|---|---|---|---|---|---|
| 7 | 0 | 2 | 14,728 | 25 | 2,115 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carelli, JD; Jain, RK; Merrick, WC; Miller, HR; Ross, NT; Sethofer, SG; Simard, JL; Smith, GA; Taunton, J | 1 |
1 other study(ies) available for ternatin heptapeptide and guanosine triphosphate
| Article | Year |
|---|---|
Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Resistance; Guanosine Triphosphate; Humans; Mutant Proteins; Mutation; Peptide Elongation Factor 1; Peptides, Cyclic; Protein Binding; RNA, Transfer | 2015 |